Cytokinetics | CYTK - Ebitda



金融业
股票价格
USD
资产
USD 1.27B
现金及等价物
USD 129.84M
销售成本
USD 160K
流动资产
USD 839.47M
流动负债
USD 199.19M
债务
USD 1.29B
EBIT
USD -181.23M
EBITDA
USD -169.32M
员工
498
EPS每股收益
USD -1.67
股本和储备
USD -826.57M
销售毛利
USD 19.2M
债务利息支出
USD 33.34M
利息收入
USD 11.02M
贷款资金
USD 247.21M
市值
USD 9.01B
净收入
USD -206.03M
营业费用
USD 200.58M
营业利润
USD -181.23M
普通股股本
USD 124.43M
税前利润
USD -206.03M
销售收入
USD 19.35M
销售和管理费用
USD 104.9M
股票
USD 154K
贸易债权人
USD 24.71M
应收帐款人
USD 6.83M


Ebitda 更改 日
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Amgen USD 5.14B 775M 2025-12
Arca Biopharma USD -25.07M 5.23M 2025-03
Bayer EUR 4.45B 2.49B 2026-03
Biogen USD 649.7M 76.5M 2026-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cytokinetics USD -169.32M 19.48M 2026-03
Eisai JPY -335M 30.43B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Exelixis USD 258.29M 15.43M 2026-03
Geron USD -21.29M 11.82M 2025-12
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03